Effects of Levosimendan on Cardiac Gene Expression Profile and Post-Infarct Cardiac Remodelling in Diabetic Goto-Kakizaki Rats
Article first published online: 17 AUG 2011
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society
Basic & Clinical Pharmacology & Toxicology
Volume 109, Issue 5, pages 387–397, November 2011
How to Cite
Vahtola, E., Storvik, M., Louhelainen, M., Merasto, S., Lakkisto, P., Lakkisto, J., Tikkanen, I., Kaheinen, P., Levijoki, J. and Mervaala, E. (2011), Effects of Levosimendan on Cardiac Gene Expression Profile and Post-Infarct Cardiac Remodelling in Diabetic Goto-Kakizaki Rats. Basic & Clinical Pharmacology & Toxicology, 109: 387–397. doi: 10.1111/j.1742-7843.2011.00743.x
- Issue published online: 12 OCT 2011
- Article first published online: 17 AUG 2011
- Accepted manuscript online: 23 JUN 2011 10:58AM EST
- (Received 21 February 2011; Accepted 23 May 2011)
Table S1. Effects of myocardial infarction (MI), sham operation and levosimendan on myocardial gene expression in diabetic Goto-Kakizaki rats. Fold changes in gene expression in: MI vs. Sham, MI + levosimendan vs. MI, Sham + levosimendan vs. Sham. Effects of MI, Sham and levosimendan on KEGG pathways in diabetic GK rat myocardium.
Table S2. RT-PCR probes and primers.
|BCPT_743_sm_TableS1.xls||5971K||Supporting info item|
|BCPT_743_sm_TableS2.xls||29K||Supporting info item|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.